Gopalani Sameer V, Qin Jin, Buenconsejo-Lum Lee, Thompson Trevor D, Miller Jacqueline W, Luther X-Ner, Reichhardt Martina, Senkomago Virginia, Palafox Neal A, Kabua Neiar, Ikerdeu Edolem, Cash McGinley Haley L
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, United States; Oak Ridge Institute for Science and Education, Oak Ridge, TN, United States.
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Cancer Epidemiol. 2025 Aug;97:102851. doi: 10.1016/j.canep.2025.102851. Epub 2025 Jun 6.
Breast, cervical, and colorectal cancer screening are recommended and can reduce mortality from these cancers, yet information on screening prevalence in the US-Affiliated Pacific Islands (USAPI) is limited.
We analyzed data from population-based cross-sectional surveys undertaken at different time points from 2016 to 2019 in American Samoa, the Commonwealth of the Northern Mariana Islands, the Republic of Palau, the Republic of the Marshall Islands, and the Federated States of Micronesia states of Pohnpei and Kosrae. We estimated the age-standardized percentage of never screened and up-to-date screening for breast, cervical, and colorectal cancer among eligible adults by select sociodemographic and health characteristics.
In the USAPI overall, 20.6 % (95 % confidence interval [CI]: 18.6, 22.8) of participants were up-to-date with breast cancer screening, 38.6 % (95 % CI: 37.1, 40.2) with cervical cancer screening, and 15.1 % (95 % CI: 13.8, 16.4) with colorectal cancer screening. Screening in the USAPI overall was lower for all three cancers among participants who reported having a high school education or less compared to those with more than a high school education. Cervical cancer screening was lower among participants with diabetes compared to those without diabetes, and colorectal cancer screening was lower among participants who reported tobacco use than among those without tobacco use.
Cancer screening was suboptimal across all three cancer types in the USAPI. Developing, implementing, or expanding culturally tailored and effective cancer screening strategies may address barriers to screening and improve access and utilization.
乳腺癌、宫颈癌和结直肠癌筛查是被推荐的，并且可以降低这些癌症导致的死亡率，然而关于美属太平洋岛屿（USAPI）筛查普及率的信息有限。
我们分析了2016年至2019年不同时间点在美国萨摩亚、北马里亚纳群岛联邦、帕劳共和国、马绍尔群岛共和国以及密克罗尼西亚联邦的波纳佩州和科斯雷州进行的基于人群的横断面调查数据。我们根据选定的社会人口学和健康特征，估计了符合条件的成年人中从未接受筛查以及乳腺癌、宫颈癌和结直肠癌最新筛查的年龄标准化百分比。
在美国萨摩亚群岛总体人群中，20.6%（95%置信区间[CI]：18.6，22.8）的参与者进行了最新的乳腺癌筛查，38.6%（95%CI：37.1，40.2）进行了宫颈癌筛查，15.1%（95%CI：13.8，16.4）进行了结直肠癌筛查。与高中以上学历的参与者相比，报告高中及以下学历的参与者中，这三种癌症的总体筛查率在美国萨摩亚群岛均较低。与无糖尿病的参与者相比，糖尿病患者的宫颈癌筛查率较低；与不吸烟的参与者相比，报告吸烟的参与者的结直肠癌筛查率较低。
在美国萨摩亚群岛，这三种癌症类型的筛查情况都不太理想。制定、实施或扩大符合文化特点且有效的癌症筛查策略可能会消除筛查障碍，改善可及性和利用率。
